You are currently viewing a new version of our website. To view the old version click .

Current Oncology, Volume 30, Issue 6

June 2023 - 50 articles

Cover Story: The approval of CDK4/6 inhibitors has dramatically improved care for the treatment of HR+/HER2– advanced breast cancer, but navigating the rapidly expanding evidence base is challenging. In this review, we provide best-practice recommendations for the first-line treatment of HR+/HER2– advanced breast cancer in Canada based on the relevant literature, clinical guidelines, and our own clinical experience. Ribociclib + aromatase inhibitor is our preferred first-line treatment for de novo advanced disease or relapse ≥12 months after the completion of adjuvant endocrine therapy, and ribociclib or abemaciclib + fulvestrant is our preferred first-line treatment for patients experiencing early relapse. Considerations for special populations are also explored. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (50)

  • Article
  • Open Access
6 Citations
5,910 Views
14 Pages

20 June 2023

The present study analyzed the characteristics of phase IV clinical trials in oncology using data from the ClinicalTrials.gov registry. The included trials were conducted between January 2013 and December 2022 and were examined for key characteristic...

  • Review
  • Open Access
60 Citations
20,963 Views
26 Pages

Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape

  • Andrew Nguyen,
  • Alexander Nguyen,
  • Oluwaferanmi T. Dada,
  • Persis D. Desai,
  • Jacob C. Ricci,
  • Nikhil B. Godbole,
  • Kevin Pierre and
  • Brandon Lucke-Wold

19 June 2023

The present review aimed to establish an understanding of the pathophysiology of leptomeningeal disease as it relates to late-stage development among different cancer types. For our purposes, the focused metastatic malignancies include breast cancer,...

  • Brief Report
  • Open Access
1 Citations
2,699 Views
8 Pages

19 June 2023

Even though the use of the “fissure-last” technique in mini-invasive lobectomy with the fissureless condition is well accepted, in terms of perioperative outcomes, controversies still surround the hilar lymph node dissection. In this arti...

  • Review
  • Open Access
8 Citations
5,919 Views
22 Pages

Neurologic Complications of Cancer Immunotherapy

  • Aseel N. Alsalem,
  • Leslie A. Scarffe,
  • Hannah R. Briemberg,
  • Ashley E. Aaroe and
  • Rebecca A. Harrison

19 June 2023

Immunotherapy has revolutionized cancer treatment over the past decade. As it is increasingly introduced into routine clinical practice, immune-related complications have become more frequent. Accurate diagnosis and treatment are essential, with the...

  • Review
  • Open Access
17 Citations
5,680 Views
13 Pages

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma

  • Samantha M. Ruff,
  • Ashish Manne,
  • Jordan M. Cloyd,
  • Mary Dillhoff,
  • Aslam Ejaz and
  • Timothy M. Pawlik

18 June 2023

The liver maintains a balance between immune tolerance and activation in its role as a filtration system. Chronic inflammation disrupts this immune microenvironment, thereby allowing for the rise and progression of cancer. Hepatocellular carcinoma (H...

  • Article
  • Open Access
5 Citations
3,558 Views
14 Pages

Lymph Node Staging in Perihilar Cholangiocarcinoma: The Key to the Big Picture

  • Nina A. Rogacka,
  • Tamas Benkö,
  • Fuat H. Saner,
  • Eugen Malamutmann,
  • Moritz Kaths,
  • Juergen W. Treckmann and
  • Dieter Paul Hoyer

17 June 2023

Klatskin tumors have a bad prognosis despite aggressive therapy. The role and extent of lymph node dissection during surgery is a matter of discussion. This retrospective study analyzes our current experience of surgical treatments in the last decade...

  • Review
  • Open Access
22 Citations
5,355 Views
14 Pages

17 June 2023

Cancer-related pain affects a majority of patients with advanced cancer and is often undertreated. The treatment of this pain is largely reliant on the use of opioids, which are essential medicines for symptom management and the maintenance of qualit...

  • Communication
  • Open Access
1 Citations
2,262 Views
7 Pages

Integrated Analysis of the RASH Study with the Use of the “Burden of Therapy” (BOTh®TM) Methodology—A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer

  • Klara Dorman,
  • Stefan Boeck,
  • Robert J. Snijder,
  • Jens T. Siveke,
  • Michael Schenk,
  • Julia Mayerle,
  • Karel Caca,
  • Jens Freiberg-Richter,
  • Ludwig Fischer von Weikersthal and
  • Frank Kullmann
  • + 11 authors

17 June 2023

This analysis of the RASH trial (NCT01729481) aimed at gaining a better understanding of the “Burden of Therapy” (BOTh®TM) in pancreatic ductal adenocarcinoma (PDAC). In the RASH study, 150 patients with newly diagnosed metastatic PDA...

  • Case Report
  • Open Access
4 Citations
3,586 Views
12 Pages

Fast Track Management of Primary Thyroid Lymphoma in the Very Elderly Patient

  • Pierre Yves Marcy,
  • Frederic Bauduer,
  • Juliette Thariat,
  • Olivier Gisserot,
  • Edouard Ghanassia,
  • Bruno Chetaille,
  • Laurys Boudin and
  • Jean Baptiste Morvan

15 June 2023

A rapid growing cervical mass mobile while swallowing is the most common clinical presentation of severe thyroid malignancy. A 91-year-old female patient with a history of Hashimoto thyroiditis presented with clinical compressive neck symptoms. The p...

  • Article
  • Open Access
2,331 Views
9 Pages

Data Dissemination of the Role of Neoadjuvant Radiation in Retroperitoneal Sarcoma: A CTOS and CSSO Survey

  • Sarah Corn,
  • Carolyn Nessim,
  • Christina L. Roland,
  • Alessandro Gronchi,
  • Carolyn Freeman and
  • Sinziana Dumitra

14 June 2023

Consensus guidelines call for complete resection of retroperitoneal sarcoma with consideration of neoadjuvant radiation for curative-intent treatment. The 15-month delay from the initial presentation of an abstract to the final publication of the STR...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729